Enables epidermal growth factor receptor binding activity. Involved in several processes, including positive regulation of DNA biosynthetic process; positive regulation of ERK1 and ERK2 cascade; and positive regulation of fibroblast proliferation. Acts upstream of or within regulation of protein transport. Located in extracellular space. Used to study perinatal necrotizing enterocolitis. Biomarker of acute kidney failure. Human ortholog(s) of this gene implicated in several diseases, including Zollinger-Ellison syndrome; hepatobiliary system cancer (multiple); high grade glioma (multiple); lung non-small cell carcinoma (multiple); and primary hypomagnesemia (multiple). Orthologous to human EGF (epidermal growth factor); PARTICIPATES IN epidermal growth factor/neuregulin signaling pathway; altered epidermal growth factor/neuregulin signaling pathway; ceramide signaling pathway; INTERACTS WITH (+)-schisandrin B; (R)-noradrenaline; 1,2-dimethylhydrazine.
EGF protein promotes the reaction [ginsenoside Rg3 affects the phosphorylation of EGFR protein] and ginsenoside Rg3 inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to EGFR protein]]
[AVP protein co-treated with Norepinephrine] inhibits the reaction [Triiodothyronine inhibits the reaction [EGF protein results in decreased expression of UCP1 mRNA]] more ...
[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of AHR mRNA] more ...
geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [EGF protein binds to EGFR protein]] and Tetrachlorodibenzodioxin inhibits the reaction [EGF protein binds to EGFR protein]
[AVP protein co-treated with Norepinephrine] inhibits the reaction [Triiodothyronine inhibits the reaction [EGF protein results in decreased expression of UCP1 mRNA]] more ...
Triiodothyronine inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] and Triiodothyronine inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]
bisindolylmaleimide I inhibits the reaction [EGF protein results in decreased expression of UCP1 mRNA] and bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of EGF protein]
1-Methyl-3-isobutylxanthine promotes the reaction [FSHB protein inhibits the reaction [EGF results in increased phosphorylation of MAPK1 protein]] and 1-Methyl-3-isobutylxanthine promotes the reaction [FSHB protein inhibits the reaction [EGF results in increased phosphorylation of MAPK3 protein]]
[Bucladesine co-treated with 1-Methyl-3-isobutylxanthine co-treated with EGF protein co-treated with FGF2 protein co-treated with NGF protein co-treated with BDNF protein] results in increased expression of ENO2 mRNA more ...
[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of AHR mRNA] more ...
EGF protein inhibits the reaction [naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK1 protein]] and EGF protein inhibits the reaction [naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK3 protein]]
Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine] and Selenium inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine]
afatinib inhibits the reaction [EGF protein results in increased expression of EHMT2 protein] and afatinib inhibits the reaction [EGF protein results in increased expression of POU5F1 protein]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[afimoxifene co-treated with EGF protein] results in increased expression of CDH1 protein] more ...
[Tretinoin co-treated with EGF protein co-treated with NOG protein] results in increased expression of SOX10 mRNA and [Tretinoin co-treated with EGF protein] results in increased expression of NKX2-2 mRNA
Amiodarone inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] and RTKI cpd promotes the reaction [Amiodarone inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]]
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of EGF mRNA
EGFR affects the reaction [arsenite results in increased secretion of EGF protein] and ERBB2 affects the reaction [arsenite results in increased secretion of EGF protein]
[Arsenic Trioxide co-treated with Pamidronate] promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein] and Arsenic Trioxide promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein]
[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Asparagine and Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Asparagine]
baicalein inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] and baicalein inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein]
baicalin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] and baicalin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein]
[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EGF mRNA
EGF protein promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA] and EGF protein promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 protein]
AHR protein affects the reaction [Benzo(a)pyrene inhibits the reaction [EGF protein binds to EGFR protein]] and Benzo(a)pyrene inhibits the reaction [EGF protein binds to EGFR protein]
Benzoic Acid analog inhibits the reaction [EGF protein promotes the reaction [STAT3 protein binds to EGFR protein]] and Benzoic Acid analog inhibits the reaction [EGF protein results in increased phosphorylation of STAT3 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EGF protein inhibits the reaction [Berberine results in decreased activity of MMP2 protein]] more ...
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of EGF mRNA
[Bucladesine co-treated with 1-Methyl-3-isobutylxanthine co-treated with EGF protein co-treated with FGF2 protein co-treated with NGF protein co-treated with BDNF protein] results in increased expression of ENO2 mRNA more ...
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of EGF mRNA
calphostin C inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] and calphostin C inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]
chelerythrine inhibits the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]] and chelerythrine inhibits the reaction [EGF protein results in decreased susceptibility to Acetaldehyde]
chrysin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] and chrysin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]] more ...
Curcumin inhibits the reaction [EGF protein results in decreased expression of PPARG mRNA] and Curcumin inhibits the reaction [EGF protein results in decreased expression of PPARG protein]
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA
[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of AHR mRNA] more ...
[Arsenic Trioxide co-treated with Pamidronate] promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein] and Arsenic Trioxide promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein]
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA
Selenium inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine] and Selenium inhibits the reaction [EGF protein results in increased abundance of Peroxides]
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EGF mRNA
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of EGF mRNA
Enzyme Inhibitors inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] and Enzyme Inhibitors inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA
Erlotinib Hydrochloride inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] and Erlotinib Hydrochloride inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]
Farnesol analog inhibits the reaction [EGF protein results in increased activity of RHOA protein] and Farnesol analog results in decreased susceptibility to [INS protein co-treated with EGF protein]
galangin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] and galangin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein]
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased acetylation of and results in increased stability of EP300 protein] more ...
[Genistein co-treated with vinclozolin] results in decreased expression of EGF mRNA and Genistein inhibits the reaction [EGF protein results in decreased secretion of REN protein]
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased acetylation of and results in increased stability of EP300 protein] more ...
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased acetylation of and results in increased stability of EP300 protein] more ...
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Hydrogen Peroxide results in increased expression of EGF] and perifosine inhibits the reaction [Hydrogen Peroxide results in increased expression of EGF]
Hydroxamic Acids analog inhibits the reaction [EGF protein promotes the reaction [STAT3 protein binds to EGFR protein]] and Hydroxamic Acids analog inhibits the reaction [EGF protein results in increased phosphorylation of STAT3 protein]
[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Arginine and Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Arginine]
[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Isoleucine and Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Isoleucine]
[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Leucine and Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Leucine]
[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Lysine and Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Lysine]
[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Methionine and Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Methionine]
[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Phenylalanine and Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Phenylalanine]
Leflunomide inhibits the reaction [EGF protein results in increased activity of ELK1 protein] and Leflunomide inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]
leptomycin B inhibits the reaction [EGF protein affects the localization of SET protein alternative form] and leptomycin B inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA
EGF protein promotes the reaction [Lithocholic Acid results in increased activity of ALPL protein] and EGF protein promotes the reaction [Lithocholic Acid results in increased activity of TGFB1 protein]
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EGF mRNA
methoxyacetic acid promotes the reaction [EGF protein results in increased activity of ELK1 protein] and U 0126 inhibits the reaction [methoxyacetic acid promotes the reaction [EGF protein results in increased activity of ELK1 protein]]
methyl-beta-cyclodextrin inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]
midostaurin inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]]
Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to ARAF protein]]] more ...
EGF protein inhibits the reaction [naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK1 protein]] and EGF protein inhibits the reaction [naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK3 protein]]
Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine] and Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of Peroxides]
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [EGF protein affects the localization of RELA protein] and benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [EGF protein results in increased secretion of MUC5AC protein]
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein] and Cycloheximide inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein]]
Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased activity of HRAS protein] and Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]
Niclosamide inhibits the reaction [EGF protein results in increased expression of HIF1A mRNA] and Niclosamide inhibits the reaction [EGF protein results in increased phosphorylation of STAT3 protein]
Okadaic Acid inhibits the reaction [EGF protein results in decreased activity of ACO1 protein] and Okadaic Acid inhibits the reaction [EGF protein results in decreased activity of IREB2 protein]
[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Ornithine and Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Ornithine]
[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EGF mRNA
[Arsenic Trioxide co-treated with Pamidronate] promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein] and Pamidronate promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein]
[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EGF mRNA
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of EGF mRNA and [EGF protein co-treated with HGF protein] promotes the reaction [Acetaminophen results in decreased expression of CYP1A2 mRNA]
perifosine inhibits the reaction [cyadox results in increased expression of EGF] and perifosine inhibits the reaction [Hydrogen Peroxide results in increased expression of EGF]
EGF protein inhibits the reaction [Permethrin results in increased expression of CYP2B1 mRNA] and EGF protein inhibits the reaction [Permethrin results in increased expression of CYP3A23-3A1 mRNA]
Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of Peroxides] and Selenium inhibits the reaction [EGF protein results in increased abundance of Peroxides]
Phenanthrolines inhibits the reaction [Tetradecanoylphorbol Acetate results in increased cleavage of and results in increased secretion of EGF protein] and Zinc inhibits the reaction [Phenanthrolines inhibits the reaction [Tetradecanoylphorbol Acetate results in increased cleavage of and results in increased secretion of EGF protein]]
Phenobarbital inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] and Phenobarbital inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein]
oxophenylarsine inhibits the reaction [EGF protein affects the localization of and results in increased activity of STAT3 protein] and oxophenylarsine inhibits the reaction [EGF protein binds to and affects the localization of EGFR protein]
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EGF mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]] more ...
PTPN11 protein affects the reaction [resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein]]
Selenium inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine] and Selenium inhibits the reaction [EGF protein results in increased abundance of Peroxides]
EGF protein promotes the reaction [sodium arsenite inhibits the reaction [BMP6 protein results in increased phosphorylation of SMAD1 protein]] more ...
[EGF protein results in decreased expression of EGFR protein] inhibits the reaction [sodium arsenite results in increased activity of MAPK1 protein] more ...
Sodium Salicylate promotes the reaction [[EGF protein co-treated with IGF1 protein] results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]
stattic inhibits the reaction [EGF protein results in increased expression of PSMB5 protein] and stattic inhibits the reaction [EGF protein results in increased phosphorylation of STAT3 protein]
EGF protein inhibits the reaction [Staurosporine results in increased activity of CASP3 protein] and EGF protein inhibits the reaction [Staurosporine results in increased activity of CASP7 protein]
Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]] more ...
fuzheng huayu inhibits the reaction [Carbon Tetrachloride results in increased expression of EGF protein] and Lipids inhibits the reaction [Carbon Tetrachloride results in increased expression of EGF protein]
AHR protein affects the reaction [benz(a)anthracene inhibits the reaction [EGF protein binds to EGFR protein]] and benz(a)anthracene inhibits the reaction [EGF protein binds to EGFR protein]
[tetrathiomolybdate results in decreased activity of SOD1 protein] inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] more ...
theaflavin inhibits the reaction [EGF protein results in increased expression of FAS mRNA] and theaflavin inhibits the reaction [EGF protein results in increased expression of FAS protein]
[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EGF mRNA
[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Tyrosine and Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Tyrosine]
[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Valine and Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Valine]
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA and [Genistein co-treated with vinclozolin] results in decreased expression of EGF mRNA
[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EGF mRNA
Wortmannin inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] and Wortmannin inhibits the reaction [EGF protein results in increased uptake of Fructose]
Zinc inhibits the reaction [Phenanthrolines inhibits the reaction [Tetradecanoylphorbol Acetate results in increased cleavage of and results in increased secretion of EGF protein]]
Zinc inhibits the reaction [Phenanthrolines inhibits the reaction [Tetradecanoylphorbol Acetate results in increased cleavage of and results in increased secretion of EGF protein]]
Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis.
Neuronal leucine-rich repeat protein-3 amplifies MAPK activation by epidermal growth factor through a carboxyl-terminal region containing endocytosis motifs.
Neuritogenesis induced by thyroid hormone-treated astrocytes is mediated by epidermal growth factor/mitogen-activated protein kinase-phosphatidylinositol 3-kinase pathways and involves modulation of extracellular matrix proteins.
Ontogeny of epidermal growth factor, transforming growth factor-alpha, epidermal growth factor receptor, and thyroid hormone receptor RNA levels in rat kidney and changes in those levels induced by early thyroxine treatment.
A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients.
Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.
The immunohistochemical expressions of epidermal growth factors, epidermal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer.
